Effect of simvastatin on endothelium-dependent vasorelaxation and endogenous nitric oxide synthase inhibitor

被引:0
作者
Jiang, JL [1 ]
Jiang, DJ [1 ]
Tang, YH [1 ]
Li, NS [1 ]
Deng, HW [1 ]
Li, YJ [1 ]
机构
[1] Cent S Univ, Sch Pharmaceut Sci, Dept Pharmacol, Changsha 410078, Peoples R China
关键词
simvastatin; vasodilation; tumor necrosis factor; endogenous nitric oxide synthase inhibitor; LDL lipoproteins;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
AIM: To investigate the effect of simvastatin on endothelium-dependent vasorelaxation and endogenous nitric oxide synthesis inhibitor asymmetric dimethylarginine (ADMA) in rats and cultured ECV304 cells. METHODS: Endothelial injury was induced by a single injection of low density lipoprotein (LDL) (4 mg/kg, 48 h) in rats or incubation with LDL (300 mg/L) or oxidative-modified LDL (100 mg/L) in cultured ECV304 cells, and vasodilator responses to acetylcholine (ACh) in the aortic rings and the level of ADMA, nitrite/nitrate (NO) and tumor necrosis factor-alpha (TNF-alpha) in the serum or cultured medium were determined. And the adhesion of the monocytes to endothelial cells and the activity of dimethylarginine dimethylaminohydrolase (DDAH) in the cultured ECV304 cells were measured. RESULTS: A single injection of LDL decreased endothelium-dependent relaxation to ACh, markedly increased the serum level of endogenous ADMA and TNF-alpha, and reduced serum level of NO. Pretreatment with simvastatin (30 or 60 mg/kg) markedly attenuated inhibition of vasodilator responses to ACh, the increased level of TNF-alpha and the decreased level of NO by LDL, but no effect on serum concentration of endogenous ADMA. In cultured ECV304 cells, LDL or ox-LDL markedly increased the level of ADMA and TNF-alpha and potentiated the adhesion of monocytes to endothelial cells, concomitantly with a significantly decrease in the activity of DDAH and serum level of NO. Pretreatment with simvastatin (0.1, 0.5, or 2.5 mumol/L) markedly decreased the level of TNF-alpha and the adhesion of monocytes to endothelial cells, but did not affect the concentration of endogenous ADMA and the activity of DDAH. CONCLUSION: Simvastatin protect the vascular endothelium against the damages induced by LDL or ox-LDL in rats or cultured ECV304 cells, and the beneficial effects of simvastatin may be related to the reduction of inflammatory cytokine TNF-alpha level.
引用
收藏
页码:893 / 901
页数:9
相关论文
共 41 条
[1]   Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits [J].
BodeBoger, SM ;
Boger, RH ;
Kienke, S ;
Junker, W ;
Frolich, JC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 219 (02) :598-603
[2]   Asymmetric dimethylarginine (ADMA):: A novel risk factor for endothelial dysfunction -: Its role in hypercholesterolemia [J].
Böger, RH ;
Bode-Böger, SM ;
Szuba, A ;
Tsao, PS ;
Chan, JR ;
Tangphao, O ;
Blaschke, TF ;
Cooke, JP .
CIRCULATION, 1998, 98 (18) :1842-1847
[3]   An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes [J].
Böger, RH ;
Bode-Böger, SM ;
Tsao, PS ;
Lin, PS ;
Chan, JR ;
Cooke, JP .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (07) :2287-2295
[4]   LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells -: Involvement of S-adenosylmethionine-dependent methyltransferases [J].
Böger, RH ;
Sydow, K ;
Borlak, J ;
Thum, T ;
Lenzen, H ;
Schubert, B ;
Tsikas, D ;
Bode-Böger, SM .
CIRCULATION RESEARCH, 2000, 87 (02) :99-105
[5]   Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia [J].
Böger, RH ;
Bode-Böger, SM ;
Sydow, K ;
Heistad, DD ;
Lentz, SR .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (06) :1557-1564
[6]   Simvastatin improves endothelial function in spontaneously hypertensive rats through a superoxide dismutase mediated antioxidant effect [J].
Carneado, J ;
de Sotomayor, MA ;
Perez-Guerrero, C ;
Jimenez, L ;
Herrera, MD ;
Pamies, E ;
Martin-Sanz, MDV ;
Stiefel, P ;
Miranda, M ;
Bravo, L ;
Marhuenda, E .
JOURNAL OF HYPERTENSION, 2002, 20 (03) :429-437
[7]   Asymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humans [J].
Chan, JR ;
Böger, RH ;
Bode-Böger, SM ;
Tangphao, O ;
Tsao, PS ;
Blaschke, TF ;
Cooke, JP .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (04) :1040-1046
[8]   Determination of N-G,N-G-dimethylarginine in human plasma by high-performance liquid chromatography [J].
Chen, BM ;
Xia, LW ;
Zhao, RQ .
JOURNAL OF CHROMATOGRAPHY B, 1997, 692 (02) :467-471
[9]   Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin [J].
Eid, HM ;
Eritsland, J ;
Larsen, J ;
Arnesen, H ;
Seljeflot, I .
ATHEROSCLEROSIS, 2003, 166 (02) :279-284
[10]   Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice [J].
Feng, QP ;
Lu, XG ;
Jones, DL ;
Shen, J ;
Arnold, JMO .
CIRCULATION, 2001, 104 (06) :700-704